Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Genomics|July 1, 1990
Assignment of the human gene for CREB1 to chromosome 2q32.3-q34A K Taylor, I Klisak, T Mohandas, et al.
Investigational New Drugs|April 1, 1992
Phase II evaluation of didemnin B in advanced adenocarcinoma of the kidney. A Southwest Oncology Group studyS A Taylor, P Goodman, E D Crawford, et al.
Journal of Virology|December 1, 1991
A discrete cis element in the human immunodeficiency virus long terminal repeat mediates synergistic trans activation by cytomegalovirus immediate-early proteinsP Ghazal, J Young, E Giulietti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1985
Long-term survival of patients with localized diffuse histiocytic lymphomaE E Vokes, J E Ultmann, H M Golomb, et al.
Cancer|June 6, 2017
Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapyMark C Korpics, Alec M Block, Brendan Martin, et al.
Investigational New Drugs|August 5, 2004
A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: a Southwest Oncology Group studyRobert P Whitehead, Jacqueline K Benedetti, James L Abbruzzese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Daily subcutaneous ultra-low-dose interleukin 2 with daily low-dose interferon-alpha in patients with advanced renal cell carcinomaJ I Clark, E R Gaynor, B Martone, et al.
Annals of Internal Medicine|December 15, 1988
The hemodynamic effects of treatment with interleukin-2 and lymphokine-activated killer cellsE R Gaynor, L Vitek, L Sticklin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanomaJ P Dutcher, E R Gaynor, D H Boldt, et al.
The New England Journal of Medicine|April 8, 1993
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphomaR I Fisher, E R Gaynor, S Dahlberg, et al.
Pageof 7